15^TH EUROPEAN BREAST CANCER CONFERENCE

25-27 March 2026, Barcelona, Spain

Call for abstracts

General Information

Abstracts submitted for presentation in EBCC-15 will be reviewed by an international panel of experts in the field of the subject and will be judged solely on the data submitted.

The final decision on the presentation format of all selected abstracts lies at the sole discretion of the Scientific Committee.
Abstracts submitted after the stipulated deadline will not be considered.

Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.

In case of any abstract related queries please contact: ebcc@eortc.org.

Abstract submission: 1 September – 3 November 2025
Late-breaking submission: 2-9 February 2026
ALL SUBMISSIONS NOW CLOSED

Abstract Submission: 1 September – 3 November 2025

Late-breaking submission: 2-9 February 2026

Submit your late breaker

Abstract Policy

LBA Policy

Poster Guidelines

Late Breaking Abstracts

Submissions closed.

Abstract Submission Deadline: 3 November

Presentation Formats

Oral Presentation

Abstracts of superior quality can be selected for presentation in a session where discussants will place the research findings into perspective.

Poster in the Spotlight Sessions

The Scientific Committee will make a special selection of posters which will be highlighted through short oral presentations followed by moderated discussion.

These sessions will facilitate dynamic exchange on selected findings of broad interest.

Poster Presentation

Abstracts that have been selected for poster presentation will be displayed on poster boards in a prominent poster viewing area.

The posters will be grouped by topic and displayed for one day.

A specific time will be devoted to poster viewing to ensure delegates have sufficient opportunity to acquaint themselves with the presented data.

Rehabilitation/Survivorship/FollowUp
Risk Factors
Screening
Supportive and Palliative Care including end of life treatmentSupportive and Palliative Care including end of life treatment
Systemic Treatment including immunotherapy, ADCs, CDKs etc: Advanced Disease
Systemic Treatment including immunotherapy, ADCs, CDKs etc: Early Disease

The copyright of the abstract(s) are retained by the author(s).
However, the author(s) give permission to the EBC Council to print the abstract(s) in the EJC as well as on the EBCC-15 website.

Submitting an abstract for presentation in EBCC-15 does not constitute registration for the conference. When selected, abstract presenters must register to attend EBCC-15.

Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.
In case of any abstract related queries please contact: ebcc@eortc.org.